ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 151

Distinct Phenotypes in Palindromic Rheumatism: Ultrasound and MRI during Palindromic Flares

Kulveer Mankia1, Maria Antonietta D'Agostino1, Laura Horton1, Jackie L. Nam2, Jane E. Freeston3, Andrew J. Grainger4 and Paul Emery5, 1Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 4U Leeds, Leeds, United Kingdom, 5NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: MRI, palindromic rheumatism and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 

Background/Purpose: Palindromic rheumatism (PR) is defined as a recurrent, self-abortive arthritis and/or para-arthritis, which progresses to RA in up to 50% patients (pts), particularly those that are anti-CCP+(1). The anatomical basis for the palindromic flare is unclear and may provide insights into the initial phases of RA. We aimed to describe the ultrasound (US) and MRI phenotype of palindromic flare, focussing on intra- and peri-articular inflammation, as compared to early RA.       

Methods: Pts were recruited from a prospective PR cohort. Palindromic flares were defined as the presence of ≥2 of pain, swelling, erythema in or around ≥ 1 joint, that later returned to normal. Comprehensive blinded US assessment (wrists, MCPs, PIPs, elbows, knees, MTPs, bilateral ECU and 2nd – 5th finger flexor tendons) was performed during flares. Tenosynovitis (TSV), peri-tendinous oedema (PTO), peri-articular soft tissue inflammation and subcutaneous (s/c) oedema were reported at each joint region. MRI was performed on the most symptomatic region during flare. MRIs were RAMRIS scored and descriptively scored by a blinded experienced reader for TSV, PTO, peri-articular soft tissue inflammation and s/c oedema. The same information was collected in the early RA pts.

Results: Twenty one flares were captured in 15 PR pts and imaged by US (21) and MRI (9) between May 2015 and April 2016 and compared with US and MRI of 16 early RA pts. The mean age of PR pts was 47 years, 10/15 (67%) were anti-CCP+ and 5/15 (33%) anti-CCP-. 13/15 (87%) were DMARD naive. All 15 pts had US (1pt had 3 flares captured, 4 pts had 2, and the remainder had 1) and 8 pts had MRI (4 anti-CCP+, 4 anti-CCP-, 1 had 2 flares captured). On US 10/15 pts (67%) had peri-articular inflammation and/or s/c oedema, in 6 pts this was without synovitis or TSV. Grey scale synovitis was present in 9/15 pts (60%), TSV and/or PTO were present in 5/15 (33%) pts. Power Doppler (PD) synovitis was present in only 3/15 (20%) pts. No erosions were found. On MRI, synovitis was present in 7/8 pts (88%), bone marrow oedema (BME) in 1 (11%) and no erosions were found. US (table 1) and MRI (table 2) lesions are shown for all palindromic flares and early RA pts.

Conclusion: PR has a distinct phenotype with peri-articular soft tissue inflammation and s/c oedema common in PR flares and occurring independently of synovitis and TSV. Synovitis and TSV appear more prevalent on MRI in anti-CCP+ rather than anti-CCP- PR pts in whom s/c oedema seems a prominent finding. The low prevalence of PD synovitis, BME and erosions further distinguishes PR flares from the imaging phenotype in RA.       (1)Russell et al. J Rheum 2006  

Palindromic Rheumatism

     Early RA
anti-CCP+ (n=15) anti-CCP- (n=6) (n=16)
Synovitis 7 (56%) 4 (67%) 7 (44%)
Tenosynovitis 3 (25%) 2 (33%) Not available
Peri-tendinous oedema 2 (13%) 0 (0%) Not available
Peri-articular  inflammation 8 (62%) 3 (50%) Not available
Subcutaneous oedema 7 (47%) 4 (67%) Not available
Erosions 0 (0%) 0 (0%) Not available

Table 1.  

Palindromic Rheumatism

  Early RA

anti-CCP+ (n=4) anti-CCP- (n=5) (n=16)
Synovitis 4 (100%) 3 (60%) 10 (62%)
Tenosynovitis 3 (75%) 3 (60%) 6 (38%)
Peri-tendinous oedema 3 (75%) 3 (60%) 0 (0%)
Peri-articular  inflammation 3 (75%) 3 (60%) 0 (0%)
Subcutaneous oedema 1 (25%) 3 (60%) 0 (0%)
Bone marrow edema 0 (0%) 1 (20%) 3 (19%)
Erosions 0 (0%) 0 (0%) 9 (56%)

Table 2.  


Disclosure: K. Mankia, None; M. A. D'Agostino, None; L. Horton, None; J. L. Nam, None; J. E. Freeston, None; A. J. Grainger, None; P. Emery, None.

To cite this abstract in AMA style:

Mankia K, D'Agostino MA, Horton L, Nam JL, Freeston JE, Grainger AJ, Emery P. Distinct Phenotypes in Palindromic Rheumatism: Ultrasound and MRI during Palindromic Flares [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/distinct-phenotypes-in-palindromic-rheumatism-ultrasound-and-mri-during-palindromic-flares/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-phenotypes-in-palindromic-rheumatism-ultrasound-and-mri-during-palindromic-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology